UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
ZIOPHARM ONCOLOGY, INC.
(Name of Issuer)
COMMON STOCK, PAR VALUE $0.001 PER SHARE
(Title of Class of Securities)
98973P101
(CUSIP NUMBER)
MAY 3, 2006
(Date of event which requires filing of this statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
|_| Rule 13d-1(b)
|X| Rule 13d-1(c)
|_| Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
notes).
Page 1 of 11 Pages
CUSIP No. 98973P101 13G Page 2 of 11 Pages
- --------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Millennium Partners, L.P.
13-3521699
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |X|
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands
- --------------------------------------------------------------------------------
NUMBER OF 5. SOLE VOTING POWER
SHARES -0-
-----------------------------------------------------------------
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 793,486
-----------------------------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING -0-
-----------------------------------------------------------------
PERSON 8. SHARED DISPOSITIVE POWER
WITH 793,486
- --------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
793,486
- --------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
|_|
- --------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.2%
- --------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
PN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 98973P101 13G Page 3 of 11 Pages
- --------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Millenco, L.P.
13-3532932
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |X|
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- --------------------------------------------------------------------------------
NUMBER OF 5. SOLE VOTING POWER
SHARES -0-
-----------------------------------------------------------------
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY -0-
-----------------------------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING -0-
-----------------------------------------------------------------
PERSON 8. SHARED DISPOSITIVE POWER
WITH -0-
- --------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
793,486
- --------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
|_|
- --------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.2%
- --------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
PN, BD
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 98973P101 13G Page 4 of 11 Pages
- --------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Millennium Management, L.L.C.
13-3804139
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |X|
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- --------------------------------------------------------------------------------
NUMBER OF 5. SOLE VOTING POWER
SHARES -0-
-----------------------------------------------------------------
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 793,486
-----------------------------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING -0-
-----------------------------------------------------------------
PERSON 8. SHARED DISPOSITIVE POWER
WITH 793,486
- --------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
793,486
- --------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
|_|
- --------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.2%
- --------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
OO
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 98973P101 13G Page 5 of 11 Pages
- --------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Israel A. Englander
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |X|
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
NUMBER OF 5. SOLE VOTING POWER
SHARES -0-
-----------------------------------------------------------------
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 793,486
-----------------------------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING -0-
-----------------------------------------------------------------
PERSON 8. SHARED DISPOSITIVE POWER
WITH 793,486
- --------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
793,486
- --------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
|_|
- --------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.2%
- --------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 98973P101 13G Page 6 of 11 Pages
Item 1.
(a) Name of Issuer
ZIOPHARM Oncology, Inc., a company incorporated under the laws of Delaware
(the "Company").
(b) Address of Issuer's Principal Executive Offices:
1180 Avenue of the Americas, 19th Floor
New York, NY 10036
Item 2(a). Name of Person Filing
Item 2(b). Address of Principal Business Office
Item 2(c). Citizenship
Millennium Partners, L.P.
c/o Millennium Management, L.L.C.
666 Fifth Avenue
New York, New York 10103
Citizenship: Cayman Islands
Millenco, L.P.
c/o Millennium Management, L.L.C.
666 Fifth Avenue
New York, New York 10103
Citizenship: Delaware
Millennium Management, L.L.C.
666 Fifth Avenue
New York, New York 10103
Citizenship: Delaware
Israel A. Englander
c/o Millennium Management, L.L.C.
666 Fifth Avenue
New York, New York 10103
Citizenship: United States
(d) Title of Class of Securities
Common Stock, par value $0.001 per share ("Common Stock")
(e) CUSIP Number
98973P101
Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check
whether the person filing is a:
(a) |_| Broker or dealer registered under Section 15 of the Act (15 U.S.C.
78o).
(b) |_| Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).
(c) |_| Insurance company as defined in Section 3(a)(19) of the Act (15
U.S.C. 78c).
(d) |_| Investment company registered under Section 8 of the Investment
CUSIP No. 98973P101 13G Page 7 of 11 Pages
Company Act of 1940 (15 U.S.C. 80a-8).
(e) |_| An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
(f) |_| An employee benefit plan or endowment fund in accordance with Rule
13d-1(b)(1)(ii)(F);
(g) |_| A parent holding company or control person in accordance with Rule
13d-1(b)(1)(ii)(G);
(h) |_| A savings association as defined in Section 3(b) of the Federal
Deposit Insurance Act (12 U.S.C. 1813);
(i) |_| A church plan that is excluded from the definition of an investment
company under Section 3(c)(14) of the Investment Company Act of 1940
(15 U.S.C. 80a-3);
(j) |_| Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
If this statement is filed pursuant to Rule 13d-1(c), check this box. [X]
Item 4. Ownership
Provide the following information regarding the aggregate number and
percentage of the class of securities of the issuer identified in Item 1.
(a) Amount Beneficially Owned
Each Reporting Person may be deemed the beneficial owner of:
(i) 231,931 shares of Common Stock that were acquired by
Millennium Partners, L.P., a Cayman Islands exempted limited
partnership ("Millennium Partners")on or about December 13,
2005, in exchange for 462,962 shares of Series A Convertible
Preferred Stock, $0.001 par value per share, of Ziopharm, Inc.
(the "Preferred Shares"). The Preferred Shares had been
acquired on April 12, 2005 pursuant to a Subscription
Agreement between Ziopharm, Inc. and Millennium Partners. The
Preferred Shares were exchanged for shares of Common Stock in
connection with Ziopharm, Inc.'s merger with EasyWeb, Inc.;
(ii) 431,965 shares of Common Stock that were issued to Millennium
Partners on May 3, 2006 in connection with a Subscription
Agreement between the Company and Millennium Partners; and
(iii) 129,590 shares of Common Stock issuable to Millennium Partners
upon exercise of a Common Stock Purchase Warrant dated May 3,
2006.
The managing partner of Millennium Partners and the general partner of
Millenco, L.P. ("Millenco") is Millennium Management, L.L.C., a Delaware limited
liability company ("Millennium Management"), and consequently Millennium
Management may be deemed to have voting control and investment discretion over
securities owned by Millennium Partners and by Millenco. Israel A. Englander
("Mr. Englander") is the managing member of Millennium Management. As a result,
Mr. Englander may be deemed to be the beneficial owner of any shares deemed to
be beneficially owned by Millennium Management. The foregoing should not be
construed in and of itself as an admission by either of Millennium Management or
CUSIP No. 98973P101 13G Page 8 of 11 Pages
Mr. Englander as to beneficial ownership of the shares owned by Millennium
Partners or Millenco.
Note: Millennium Partners is a limited partner of Millenco. As a limited
partner, Millennium Partners has no investment or voting control over Millenco
or its securities position.
(b) Percent of Class
As of the close of trading on the date of this filing, each Reporting
Person may be deemed the beneficial owner of 793,486 shares of Common Stock, or
5.2% of the Company's issued and outstanding shares of Common Stock (which
percentage was calculated based on a figure of 15,264,248 outstanding shares of
Common Stock as of May 3, 2006, as reported on the Company's Current Report on
Form 8-K dated May 3, 2006 and filed with the Securities and Exchange Commission
on May 3, 2006).
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote:
-0-
(ii) Shared power to vote or to direct the vote
793,486
(iii) Sole power to dispose or to direct the disposition of
-0-
(iv) Shared power to dispose or to direct the disposition of
793,486
Item 5. Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more than
five percent of the class of securities, check the following | |.
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
Not applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company
Not applicable.
Item 8. Identification and Classification of Members of the Group
See Exhibit I.
Item 9. Notice of Dissolution of Group
Not applicable.
CUSIP No. 98973P101 13G Page 9 of 11 Pages
Item 10. Certification
By signing below each of the undersigned certifies that, to the best of its
knowledge and belief, the securities referred to above were not acquired and are
not held for the purpose of or with the effect of changing or influencing the
control of the issuer of the securities and were not acquired and are not held
in connection with or as a participant in any transaction having that purpose or
effect.
Exhibits:
Exhibit I: Joint Filing Agreement, dated as of May 9, 2006, by and among
Millennium Partners, L.P., Millenco, L.P., Millennium Management, L.L.C. and
Israel A. Englander.
CUSIP No. 98973P101 13G Page 10 of 11 Pages
SIGNATURE
After reasonable inquiry and to the best of its knowledge and belief, each of
the undersigned certifies that the information with respect to it set forth in
this statement is true, complete, and correct.
Dated: May 9, 2006
MILLENNIUM PARTNERS, L.P. MILLENCO, L.P.
By: Millennium Management, L.L.C. By: Millennium Management, L.L.C.
its general partner its general partner
By: /s/ Terry Feeney By: /s/ Terry Feeney
---------------------------------- ---------------------------------
Name: Terry Feeney Name: Terry Feeney
Title: Chief Operating Officer Title: Chief Operating Officer
MILLENNIUM MANAGEMENT, L.L.C.
/s/ Israel A. Englander by Simon
Lorne pursuant to Power of Attorney
filed with SEC on June 6, 2005 By: /s/ Terry Feeney
- ------------------------------------- ---------------------------------
ISRAEL A. ENGLANDER Name: Terry Feeney
Title: Chief Operating Officer
CUSIP No. 98973P101 13G Page 11 of 11 Pages
EXHIBIT I
JOINT FILING AGREEMENT
This will confirm the agreement by and among the undersigned that the Schedule
13G filed with the Securities and Exchange Commission on or about the date
hereof with respect to the beneficial ownership by the undersigned of the Common
Stock, par value $0.001 per share, of ZIOPHARM Oncology, Inc., a company
incorporated under the laws of Delaware, is being filed, and all amendments
thereto will be filed, on behalf of each of the persons and entities named below
in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as
amended. This Agreement may be executed in two or more counterparts, each of
which shall be deemed an original, but all of which together shall constitute
one and the same instrument.
Dated: May 9, 2006
MILLENNIUM PARTNERS, L.P. MILLENCO, L.P.
By: Millennium Management, L.L.C. By: Millennium Management, L.L.C.
its general partner its general partner
By: /s/ Terry Feeney By: /s/ Terry Feeney
---------------------------------- ---------------------------------
Name: Terry Feeney Name: Terry Feeney
Title: Chief Operating Officer Title: Chief Operating Officer
MILLENNIUM MANAGEMENT, L.L.C.
/s/ Israel A. Englander by Simon
Lorne pursuant to Power of Attorney
filed with SEC on June 6, 2005 By: /s/ Terry Feeney
- ------------------------------------- ---------------------------------
ISRAEL A. ENGLANDER Name: Terry Feeney
Title: Chief Operating Officer